International Staging System for Multiple MyelomaPhilip R. Greipp, Jan Westin, Jesús F. San Miguel et al.|Journal of Clinical Oncology|2005Cited by 2.9k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATIONJoan Bladé, David H. Vesole, Diana Samson et al.|British Journal of Haematology|1998Cited by 1.5k
Prevention of thalidomide- and lenalidomide-associated thrombosis in myelomaAntonio Palumbo, Meletios Α. Dimopoulos, Paul G. Richardson et al.|Leukemia|2007Cited by 839
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disordersAngela Dispenzieri, Robert A. Kyle, Giampaolo Merlini et al.|Leukemia|2008Cited by 808
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group studyShaji Kumar, J H Lee, Juan José Lahuerta et al.|Leukemia|2011Cited by 721